Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-06

Clinical Trial Update: Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI

View source ↗

Summary

Completed clinical trial evaluating a GnRH antagonist to prevent premature luteinization in patients undergoing intrauterine insemination (IUI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH antagonist

Snippet

Sponsor: IVI Madrid | Conditions: Infertility | Status: COMPLETED